Skip to main content
Affluent Medical logo

Affluent Medical — Investor Relations & Filings

Ticker · AFME ISIN · FR0013333077 LEI · 969500N30CO4B5N2GN67 PA Manufacturing
Filings indexed 273 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country FR France
Listing PA AFME

About Affluent Medical

https://www.affluentmedical.com

Affluent Medical is a clinical-stage medical technology company that develops innovative, minimally invasive implants designed to restore essential physiological functions. The company's activities are concentrated in two primary therapeutic areas: structural heart disease and urology. It specifically addresses severe mitral valve insufficiency and urinary incontinence. The product pipeline, currently in clinical development, features three key devices: Kalios™, an adjustable annuloplasty ring for mitral valve repair; Epygon™, a biomimetic mitral valve for replacement procedures; and Artus™, an electronic artificial urinary sphincter for treating urinary incontinence. Affluent Medical's technologies are engineered to be adjustable and biomimetic, allowing for implantation via minimally invasive surgery and adaptation to both the patient's anatomy and the progression of their pathology.

Recent filings

Filing Released Lang Actions
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software.
Regulatory Filings
2026-05-04 English
Carvolix annonce des résultats positifs du programme clinique post-commercial évaluant le logiciel TAVIPILOT IA.
Regulatory Filings
2026-05-04 French
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software.
Regulatory Filings
2026-05-04 English
Document d'enregistrement universel 2025
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-04-30 French
Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.26.
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release disclosing the number of shares composing the capital and the total number of voting rights as of 31/03/2026, as required by French Commercial Code and AMF regulations. This falls under “Declaration of Voting Results & Voting Rights Announcements” (code DVA), since it is an official announcement of voting rights figures.
2026-04-14 French
Carvolix : Nombre dactions composant le capital social et nombre total de droits de vote au 31.03.26.
Regulatory Filings Classification · 88% confidence The document is an EQS regulatory press release disclosing the total number of shares and voting rights as of 31.03.2026 in accordance with French commercial and AMF regulations. It is not an earnings release, dividend notice, management report, M&A, or share issue announcement; instead it is a routine regulatory disclosure. This falls under the general Regulatory Filings (RNS) category as a fallback for regulatory announcements of this nature.
2026-04-14 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.